Slørdal L, Andersen A, Warren D J
Department of Clinical Pharmacology, Norwegian Radium Hospital, Oslo.
Ther Drug Monit. 1993 Aug;15(4):328-33. doi: 10.1097/00007691-199308000-00011.
A sensitive high-performance liquid chromatographic (HPLC) method for measuring the anthracene derivative, mitoxantrone, in plasma is described. After protein precipitation with 5-sulfosalicylic acid, samples are resolved by isocratic elution from a C18 reverse phase support and quantified by ultraviolet (UV) detection. Recovery of mitoxantrone after deproteinization was > 70%. Within-run and between-day coefficients of variation (CVs) were 5.1 and 13.7%, respectively, at mitoxantrone concentrations of 20 nM (n = 6). The limit of detection was 2.5 nM and the standard curve linear up to 1 microM. Stability studies have shown that mitoxantrone is stable in spiked whole blood for 3-6 h, provided the samples are kept on ice. The drug is stable in plasma and deproteinized plasma samples for at least 24 h. The method requires few manipulations and is readily adaptable to automation.
本文描述了一种灵敏的高效液相色谱(HPLC)法,用于测定血浆中的蒽环类衍生物米托蒽醌。用5-磺基水杨酸进行蛋白沉淀后,样品在C18反相柱上通过等度洗脱进行分离,并通过紫外(UV)检测进行定量。去蛋白后米托蒽醌的回收率>70%。在米托蒽醌浓度为20 nM(n = 6)时,批内和批间变异系数(CVs)分别为5.1%和13.7%。检测限为2.5 nM,标准曲线在高达1 μM范围内呈线性。稳定性研究表明,只要样品保存在冰上,米托蒽醌在加标的全血中可稳定3 - 6小时。该药物在血浆和去蛋白血浆样品中至少稳定24小时。该方法操作简便,易于实现自动化。